Tuesday, 30th June 2020  
A higher priority for health
UEHP read with enthusiasm the recent announcement by the European Commission concerning Health in Europe. We transcribe here part of the statement: “The EU4Health Programme will set out key action areas such as improvement of national health systems, measures against communicable and non-communicable diseases, availability and affordability of medicines and other crisis relevant products. Europe needs to give a higher priority to health. The new Programme will be essential in making sure that the EU remains the healthiest region in the world.”
This challenge is our challenge also. UEHP is available to participate in any action centered on innovative and efficient solutions. In the next months, we will present to the Commission relevant information supporting this common ambition, to safeguard and improve the health of European citizens. The recent crisis and the engagement of private hospitals to respond to emergency situations, demonstrate the benefits and the importance of partnership between all providers. We have to prepare the future all together!
Dr Paul Garassus
President of UEHP
Virtual Council Meeting – 26 June 2020
Last 26 June, UEHP held its very first Virtual Council meeting in its history. Due to the COVID19 pandemic, the UEHP Board decided to organise a virtual Council meeting for the safety of all members.
The meeting was dedicated mostly to the presentation of the COVID19 and post COVID19 situation in each member country and how each UEHP member has dealt with the pandemic, what were the major difficulties, what kind of support hospitals had from their governments, how is the situation now and if the activity is starting back again and to which extent.
After this important and useful detailed update from all UEHP members, we discussed only top priority topics, including the activity report and future actions by the President and Secretary General, the new UEHP projects for the years to come, the Europe’s Beating cancer Plan, and the financial situation of the association.
We thank all UEHP members for their active participation to our virtual Council meeting and we look forward to the next Council meeting in Autumn 2020.
Just published! Final report of the UEHP - SHAM workshop on Hospital Risk
Management: creating a community of experts in Europe and improving patient safety
The final report of the UEHP - SHAM workshop on Hospital Risk Management is available!
Last 22 January, the European Union of Private Hospitals organised a workshop on Hospital Risk Management, in close partnership with Relyens-SHAM, Hospital Mutual Insurance Company, European leader in hospital risk.
In a context of multi-factor transition faced by European healthcare systems, a new set of complexities arises: new technology implementation, relationship with patients, social networks, regulation according to national laws and European directives. Those factors are changing equilibrium with potential underlying risks going beyond current resilience. Risk Management offers levers to secure and optimize operations, with the need for an innovative approach to adapt to emerging and evolving risk profiles.
In this context, and following up on the first edition organised in November 2018, UEHP and SHAM teamed up to organise an interactive working session on innovation in hospital risk management in Brussels, at the hearth of the EU. During this one day session, participants could benefit from a selective panel of experts and counterparts to foster active contribution, interactivity, mutual thinking and share lessons learnt from various experience and concrete actions from all over Europe. The workshop offered a platform to discuss on the latest trends on Risk management, as well as to network with top European Executives and Risk Managers and discuss about experiences, problems and best practices.
We had an intensive full day working session with participants coming from 7 different European countries and experts from the leading European hospitals groups sharing their knowledge on how Risk Management is evolving.
The morning session was dedicated to Germany, with a focus on the approach and methodologies from two of the main hospitals groups in Germany, Sana Kiniken and Asklepios Kliniken.
The second part of the morning was dedicated to the Roundtable “Crossing the bridge from theory to practice: what works (…and not)”, where panellists coming from the leading hospitals groups from Italy (Humanitas San Pio X, Gruppo San Donato), France (Ramsay Santé) and Spain (Quironsalud) shared their experiences on mitigating and preventing clinical risk.
The afternoon session was dedicated to two inspiring presentations, on the new borders of Risk management and to cybersecurity trends in healthcare.
After that the participants split into three different groups to take part to three different thematic workshop on
  • Healthcare Associated infections – what are the main triggers of event prevention? What strategies to put in place?
  • The Healthcare professional crisis – how to deal with th current crisis?
  • Use of healthcare data to reduce risk – which data to be leveraged in order to improve its risk diagnosis?
Both UEHP and SHAM teams wish to deeply thank all participants and speakers for their valuable contributions. We will build on the outcomes of this workshop and keep sharing knowledge and possible solutions to prevent and mitigate risks and keep ensuring the best quality and safety of treatments to all patients.
EU4Health Programme, the EU’s response to the COVID19 pandemic
COVID-19 has had a major impact on medical and healthcare staff, patients and health systems in Europe. The pandemic has revealed a clear need to strengthen crisis management and health systems.
It has in particular demonstrated that the EU needs:
  • more coordination between Member States during a health crisis;
  • more capacity at EU level to prepare for and to fight health crises; and
  • more investment in health systems to make sure they are ready for the challenges of tomorrow.
By investing €9.4 billion, EU4Health Programme will:
  • boost EU’s preparedness for major cross border health threats
  • make sure health systems are resilient and can face epidemics as well as long-term challenges such as an ageing population and inequalities in health status.
Through the EU4Health Programme, the Commission proposes to invest €9.4 billion in strengthening health systems. This is compared to the previous Commission proposal for a health strand under the European Social Fund+ of €413 million. The funding will partly come from the EU budget (€1.7 billion), partly via external assigned revenues, stemming from the borrowing operations of the Union as set out in the EU Recovery Instrument Regulation (€7.7 billion). There will be no pre-allocation for each of the objectives mentioned in the programme. The distribution will be agreed upon during the implementation of the EU4Health programme.
This proposal provides for a date of application as of 1 January 2021 and is presented for a Union of 27 Member States.
“We will stop at nothing to save lives,” said President von der Leyen, speaking to the European Parliament on 26 March 2020, the COVID-19 crisis is the biggest challenge the European Union (EU) has faced since the Second World War, and it has demonstrated that if each country tries to tackle pandemics on its own, the EU will be as weak as the weakest link. Every health system has struggled in tackling this crisis, and this has affected every citizen in one way or another.
Europe needs to give a higher priority to health, to have health systems ready to provide state of the art care, and to be prepared to cope with epidemics and other unforeseeable health threats in line with the International Health Regulations (IHR).
The new Programme will be essential in making sure that the EU remains the healthiest region in the world, has all possible tools available to address health challenges at national and EU level and is prepared for any new emerging health threat that may endanger the population of the EU.
Embedded in the ‘One health’ approach, which recognises the interconnection between human health and animal health and more broadly with the environment, the EU4Health Programme can support Member States in the transition to better preparedness and the reinforcement of their health systems and support them in achieving the health-related United Nations Sustainable Development Goals (SDGs). It provides for new actions, which will fill in gaps that this pandemic has revealed in terms of the development and manufacturing of medicinal products, the adequate supply of equipment in hospitals and sufficient medical human resources, the uptake of digital tools and services that enable continuity of care, and the need to maintain access to essential goods and services in times of crisis. This will allow the EU to have more tools to take quick, decisive and coordinated action with the Member States in both preparing for and managing crises.
For more detailed information:
EU long-term budget 2021-2027: Commission Proposal May 2020:
The EU Health Coalition calls for an ambitious EU4Health programme for Europe to take the lead in healthcare
COVID-19 has exacerbated many of the existing, underlying problems of healthcare systems. At the same time, it has highlighted the devastating impact that serious public health threats can have on both the health and wellbeing of our citizens as well as on our economies. The current crisis has clearly demonstrated how healthy populations and economic growth are interdependent and mutually reinforcing.
Health now sits at the top of the European political agenda – and this momentum must not be lost. Therefore, we welcome the European Commission’s EU4Health programme proposal, with its €9.4 billion budget supported via the Multiannual Financial Framework and the Next Generation EU recovery instrument. Investments in public health and healthcare systems will ensure that a similar health crisis never impacts European countries so profoundly again, while playing a vital role in stimulating the economic recovery of Europe.
The first strand of the proposed programme will address health security and crisis preparedness. As the EU Health Coalition, we particularly welcome the second strand, which is aimed at supporting the longer-term vision of improving health outcomes through more efficient and inclusive health systems. The emphasis on strengthening the capabilities of the European Centre for Disease Control, on measuring standardised health outcomes throughout Europe, on the digital transformation of health systems, on expanding the European Reference Networks beyond rare diseases and on spreading best practices, amongst others is welcome. These are all priorities that we had identified in our 2018 joint recommendations for a shared vision for the future of health in Europe.
Collecting health data and sharing best practices is increasingly important, which is why we support establishing a fully scaled European Health Data Space. This way, we can achieve a ‘triple win’ for Europe: improving quality of care, building sustainable health systems and ensuring economic growth and job creation. With the digital transformation of health and care, health and digital literacy become prerequisites to build trust in, and ensure equitable access to, innovative technologies that may lead to better health outcomes.
We also need a long-term research ecosystem that helps support interdisciplinary networks, cross-border initiatives, health data infrastructures, robust collaboration, medical education and regulatory flexibility. In order to tackle our major health challenges, we need to develop a coordinated and strategic approach to plan health research, linked to the need of wider health policy.
We call on the European Commission to facilitate a permanent, multi-stakeholder forum for better access to health innovation. This should provide a space where all stakeholders – Member States, national and regional authorities, patients, civil society, healthcare professionals and industry – can come together to collaborate. It should provide a platform for discussion – together with policymakers – on the drivers and barriers to access health innovation, be they therapies, technologies, care pathways or healthcare services.
All of these could be facilitated through the EU4Health programme, allowing Europe to take the lead in areas such as research and innovation, health data and digital health, healthcare systems and health policies. It is time for the EU to play its important role in ensuring a healthy and equitable future for everyone.
Webinar on cybersecurity in Healthcare
UEHP organizes a webinar in close partnership with COCIR, the European Trade Association representing the medical imaging, radiotherapy, health ICT and electromedical industries, on CYBERSECURITY IN HEALTHCARE next 30 June 2020, from 14:00h - 15:30h.
As the digitization of health and care progresses, the number of connected digital health technologies is increasing. This is inevitably accompanied by a growing number of cybersecurity risks. Cybersecurity is a shared responsibility. It must be clear to all parties involved that it takes organisational measures to ensure security, which can then be supported by product technology.
This webinar will be an opportunity to understand the latest status on legislative developments and explore the concrete meaning and practical implementation of 'shared responsibilities', including the need for collaboration, communication and information between manufacturers and healthcare delivery organisations.
Please find attached the invitation. If you wish to register please click on “Register here” in the pdf attached or visit: https://register.gotowebinar.com/register/6323171932022282255
I hope you will be able to virtually join us for this webinar. Please do not hesitate to share this invitation with your members and contacts.
Launch of the Health System Response Monitor (HSRM)
The European Observatory on Health Systems and Policies, together with the WHO Regional Office for Europe and the European Commission, has just created and launched the Health System Response Monitor (HSRM).
It has been designed in response to the COVID-19 outbreak to collect and organize up-to-date information on how countries are responding to the crisis. It focuses primarily on the responses of health systems but also captures wider public health initiatives.
The Health System Response Monitor (HSRM) features a range of services like:
  • cross-country analysis
  • up-to-date information on health systems responses and other public health initiatives related to the COVID-19 crisis in each Country
  • comparative country responses
  • Important links and articles related to the COVID-19 crisis.
Read the article How do countries adjust hospital payment systems for COVID-19?
You can even subscribe to the HSRM bulletin and you can select the Countries about which you wish to receive information.
More information here
Cry for help from the Spanish private hospitals
Press release from the Spanish Private Health Alliance (ASPE) on 25 June 2020
Abandoned by the Spanish government and without fiancial compensation by the Autonomous Regions, the Spanish private health care fears the bankruptcy of many of its health care centers.
The Spanish Private Health Alliance (ASPE), which groups more than 1,300 health entities and represents more than 80% of the Spanish private healthcare institutions, has been asking the Spanish Government for financial aid and compensation for three months to alleviate the economic deterioration caused for the service activity carried out during the public health pandemic, and the consequent impact on the sector as an essential activity without measures of labor reorganization.
The private sector is extremely concerned about the risk, already announced weeks ago, of healthcare and financial bankruptcy and denounces the disengagement by the current government from a sector that employs 266,000 people and represents 3.4% of GDP. This risk has been exacerbated during the recently completed state of alarm and leads today to the suspension of payments, competitions and closings of hundreds of health centers, mainly small clinics, unable to bear current expenses. It is currently estimated that about 2,400 health centers without hospitalization will be forced to close.
Staffed and vacant health centers
The Government, fundamentally through the Ministry of Health, has committed during this time to a response that do not meet ASPE's request for fiscal and financial measures for companies that have been through in many cases extreme situations: open as an essential activity, without patients due to confinement, with an abysmal fall in income and without solutions for labor reorganization. Today, these centers welcome about a third of the consultations they were usually completing before the state of alarm, due to the fear of contagion, the security measures and the new patient flow management.
It is necessary to convey a sense of trust to the population, for patients to know that they can go again to their doctors, specialists and usual health centers. It is safe since numerous, precautionary and preventive measures were taken against the coronavirus.
No response from the Health Department
At the beginning of June, in a meeting with the president of ASPE, Carlos Rus, Minister Salvador Illa committed to a 10-day response to specific measures to provide financial solutions and fiscal measures: compensation for patient care derived from the public care and compensation for making health care resources available under the sole command of the health authorities and the health departments of the regional governments; and a super-reduced VAT on purchases of health equipment and supplies, with effect from the activation of the state of emergency.
At the same meeting, the sector asked to be prioritized in the distribution criteria that would be set by the Royal Decree of the autonomous health fund of 9 billion euros. The Royal Decree Law 22/2020 published on 16 June and regulating the creation of the COVID-19 Fund, stated that only the regional governments could provide a financial aid to the sector.
Except for the compensation agreement already decided with the Generalitat of Catalonia for each patient and resource used, there are currently no other agreement reached with the other regional governments where compensation has been requested. However, negotiations are progressing, with varying degrees of progress, with the governments of Madrid, Murcia, the Canary Islands, Galicia, Andalusia, the Basque Country, Castile and Leon, the Balearic Islands, La Rioja, Navarre and Valencia.
A crisis with high economic impact
The impact of COVID-19 on the private healthcare sector during the most critical months of the pandemic, March and April, is documented through a study conducted by ASPE. This study analyses the healthcare activity carried out and its impact on invoicing, employment, supply costs and investments during the mentioned period.
The study was carried out on a sample of 124 health centers, which represent 27% of private hospitals and 24% of private beds. It is sufficiently representative to draw a picture of the impact that COVID-19 has had on the private healthcare sector.
The 124 private hospitals participating in the survey accounted for 16% of diagnosed patients (19,289) and 14% of ICU admissions (1,536). As regard to the activity, all healthcare areas were significantly affected: specifically, surgical interventions decreased by 83%, diagnostic tests by 79% and the emergency department by 73%, consultations by 67%, hospital admissions by 58%, laboratory determinations by 57% and ICU admissions by 52%.
The impact on billing varies depending on the region, with Murcia, La Rioja, Cantabria and Asturias being the ones that have suffered the greatest decrease. On the contrary, Madrid, Castilla y León and Catalonia have been the communities that have been less affected. The drop in billing is lower in regions having treated a greater number of COVID-19 patients and having billed insurance company activity corresponding to previous months. The centers without hospitalization have faced a drop in revenue by 85% on average compared to the usual pre-COVID activity and the hospital centers by 60%.
Regarding the hiring of staff, despite the difficulties expressed, 89% of the centers hired new professionals during the crisis.
The hospitals participating in the study have made investments related to COVID-19 worth more than 13,5 million euros and have cancelled or delayed investments worth an estimated 36,2 million euros. 33% of the investments made correspond to the purchase of equipment, 28% to the purchase of respirators, 12% to the adaptation of spaces, and the remaining 27% to other investments.
The purchase of medical supplies related to COVID-19 has increased by 71% compared to the amount spent during 2019. The price of surgical masks has increased by 1.423% compared to December 2019.
Oscar Gaspar elected Vice President of BusinessEurope
June 2020 - Oscar Gaspar, President of APHP and Vice President of the Executive Committee of CIP was elected Vice President of BusinessEurope for a one-year term with effect from 1 July.
BusinessEurope is the largest confederation of European companies and brings together 40 business and industrial confederations from 34 countries, representing more than 20 million companies.
This mandate now beginning is particularly important since  during this period it will be up to CIP to make the link  between the Portuguese Presidency of the EU and BusinessEurope.
The Covid-19 crisis, an accelerator of teleconsultation
Arthur Thirion, Director of Doctolib France.
Did the Covid-19 crisis accelerate the use of digital tools within the medical profession? To what extent and how so?
From the very first days of the epidemic, Doctolib committed itself to ensure continuity of care by equipping free of charge 35 000 private physicians and 70 hospitals with its video consultation service to enable them to continue monitoring their patients remotely.
To get an idea of ​​this acceleration, just look at the figures: 4.6 million appointments made through video consultation on Doctolib since early March (compared to 100 000 before the epidemic). This massive increase speaks for the usefulness of this tool, for practitioners as well as for patients, not only during confinement but also in the time after. Indeed, since the end of confinement, Doctolib has registered 30 times more video consultations than before the epidemic.
But Doctolib's contribution did not stop at teleconsultation. We have also launched support plans for private practices to help them continue seeing their patients in their office, thanks to a new management of their calendars with areas dedicated to patients suspected or affected by Covid-19. This new management was especially designed to strengthen communication between patients and practitioners, a communication which is essential in normal times and even more vital in a crisis of such magnitude.
The crisis has highlighted the fragility and vulnerability of our health professionals at the heart of our healthcare system and has shown, to the French people, their major role. This crisis will quite probably, and rightly so, push us to consider the healthcare system as an investment and not as an expense: it is necessary to invest in people and in services, especially in the organization and the «logistics» of the healthcare system. These services already existed, and Doctolib has enabled an acceleration of this "logistics" to overcome the crisis.
In the countries where Doctolib is established (and in those targeted), what growth do you expect?
With the significant increase of digital use during the epidemic, Doctolib has risen to third place in the world for video consultation tools. I am convinced that this practice will settle long-term, as the Ministry of Health and the medical unions have been hoping for since September 2018.
Before the health crisis, we had already seen a demand from patients and doctors, this service was even developed in 70 hospitals ( for 2,000 practitioners in these structures).
However, 2 important elements:
It will not replace face-to-face consultation. It will probably represent between 15 and 20% of the activity of physicians who use it, as it is the case in the Nordic countries or certain Asian countries where this practice is already common.
It must be used for patients already followed up by doctors in accordance with their care pathway and their attending physician.
But teleconsultation is a proven practice. It allows better care of patients by improving access to care and increasing the frequency of contact with doctors, providing working comfort to health professionals while paying them well for all the work done and collaborating better with the nurses.
Regarding our growth, we continue to sign up nearly 4 000 new users each month in France.
And we are preparing new services with remarkably high added value for healthcare professionals and patients and we therefore plan to diversify our offer and increase the number of our customers.
According to Doctolib, what should post-Covid medical world look like?
This crisis has brought to the fore what we have always said: the need to bring health financing closer to innovation in health. Innovative technologies are the key to modernizing the system and making it more efficient. We hope that this can change now that Covid-19 has shown us this need, at the national level in France but also at the European level.
At Doctolib we do not believe in a digital medicine where patients consult a different doctor each time: this practice, recurrent because it is necessary during the crisis, must rightfully give way to the structured care pathway and to the relationship of trust between patient and practitioner. The role of the attending physician, who can now be consulted by video consultation as well as face-to-face, is essential and we are convinced that he must be included in a structured and regionalized care pathway. It is within this framework that we position ourselves with two main objectives: 1 / create the hospital and the office of the future where the digital leaves more room for the human, by reducing the administrative time and therefore by freeing up available medical time, and 2 / improve the care pathway and patient experience.
This is what we were already doing before Covid-19, and this is what we will continue doing after.
Coronavirus Immunization Study in the population of Suceava municipality
Medlife, one of the Patronatul Furnizorilor de Servicii Medicale Private – PALMED’s members and one of the leaders of the Romanian medical services market, announces the completion of a study on natural immunization of the population for COVID 19.
The research is being focused on Suceava county, as the largest outbreak of infection for the new coronavirus in Romania. The main objective of the study is to measure the immunization rate of the new coronavirus and the risk of infection, as a result of the relaxation measures.
Main conclusions
  • 20% of Suceava's 25+ population was naturally immunized for COVID 19;
  • The natural immunization rate is 29% in the 45-54 age group, and 3 times lower among young people aged between 25 and 34 years old;
  • Age is the main demographic characteristic that discriminates in what concerns the share of those who have developed specific antibodies against the new coronavirus;
  • Social class is also an important discriminator in what concerns the proportion of those who have been immunized as a result of infection with the new one coronavirus; among the immunized, fewer high-income employees with education superiors, but also entrepreneurs, directors or managers;
  • Approx. 3,100 inhabitants of Suceava was over 25 years old Positive PCR at the time of development study;
  • of these, 1 in 10 people diagnosed with COVID’19 became infected recently, with less than 20 days before the test period;
  • 20% of the target population, 16.500 people were immunized naturally following SARS CoV 2 infection.
Regarding the infection rate, the study shows that out of the 512 Suceava tested, 3.7% were confirmed positive for the new coronavirus, which were communicated to DSP according to the protocols in force. Compared to the number of inhabitants over 25 years old in Suceava, this percentage indicates that at this moment over 3000 inhabitants in Suceava are carriers of the virus. At the same time, the study data show that all test subjects whose RT-PCR test was positive did not show any symptoms at the time of testing. According to MedLife representatives, the result is interesting because it shows a much different clinical picture than the one described in the studies published in the first month of the pandemic.
According to internationally published data, asymptomatic patients screened with IgV anti-SARS CoV 2 positive and RT PCR positive in nasal and pharyngeal exudate most likely no longer have an infectious risk for contact. The dynamics of RT PCR and IgG antibodies show a significant decrease in viral load after the first 7 days after the onset of the disease, and IgG antibodies appear after day 14, which is associated with decreased risk of contagion. According to data published by South Korean authors, a positive PCR RT test after declaring a cure through two negative tests is more like residual genetic material in nasopharyngeal epithelial cells and less replicative virus.
The MedLife study took place between 18 and 28 May 2020, on a sample of 512 people, among the population of Suceava over 25 years old. The research was performed to determine the degree of natural immunization of the population for COVID 19 with the development of IgG antibodies and the level of infected with the new coronavirus.
Two test methods were used for this study: the molecular method RT-PCR considered gold standard for the detection of Sars CoV 2 virus and the serological test by the Chemiluminescence method for the determination of IgG antibodies.
Having an overview as a result of the study, Medlife believes that the situation in Suceava is relevant and that isolation measures have been welcome. If we refer to the results of our first study, conducted nationwide and which indicates that less than 2% of Romanians had antibodies a few weeks ago, it was natural to resort to isolating the outbreaks. Moreover, both the results of the first study and the results of the second show us that the Romanian population is more resistant to the virus than initially estimated, but this does not mean that we must give up protection measures and those of social distancing. We believe that all indications from the Ministry of Health must be followed carefully because there are still a significant number of asymptomatic patients who can spread the disease. It is necessary to protect especially the elderly and those who have medical conditions that, associated with Sars CoV 2 infection, can have very serious consequences.
La Tour Hospital, Meyrin/Geneva
The many faces of the La Tour Hospital
Rodolphe Eurin, Director
The La Tour Hospital, the only private healthcare establishment in the canton of Geneva equipped with an intensive care department, was strongly involved during the Covid crisis by taking charge of the entire operating programme of the Geneva University Hospitals (HUG), designated first resort for welcoming Covid + patients.
As explained by Rodolphe Eurin, director of the La Tour Hospital, the activity first came to an abrupt halt on March 13 following a decision by the Federal Council, then the hospital reorganized itself to accommodate all the patients referred by the HUG. In the end, many patients without supplementary insurance were admitted - about six times more than in normal times - considerably modifying the hospital's income structure. The shortfall for March and April has exceeded 75%, so the hospital is currently negotiating with the canton to compensate for the costs of requisitioning its facilities. On the other hand, staff on short-time working continued to receive 100% of their salary, whereas insurance normally covers only 80%.
Since 27 April, activity has gradually resumed, but has not yet reached the pre-Covid level. Some patients, for fear of contamination, are postponing their consultations or elective procedures.
The crisis is also an opportunity
Telemedicine consultations have been well received by patients and practitioners have adapted their practices to the situation to avoid disruptions in care. Emergency telemedicine was implemented using a digital sorting application, facilitating online emergency consultations, reducing not only the waiting time and the risk of contagion, but also consultation costs. In the future, outpatient surgery care will be preferred compared to hospitalization.
In addition, this extraordinary situation has made it possible to highlight the care professions, the employees and their commitment, as well as the rich and supportive social fabric of an entire region. Wishing to thank its employees for their commitment during the pandemic, the La Tour Hospital decided to support the economic fabric of Meyrin by offering its employees 1,500 meal vouchers in 10 restaurants near the hospital. A doubly winning and supportive initiative.
And throughout the Covid crisis, the La Tour Hospital posted a series of testimonials on social networks in the form of video clips, of the hospital's healthcare workers, on the front line facing the pandemic. An original idea to decompartmentalize in time of confinement and bring out the invaluable work of the teams.
A sustainable medicine
And in recent days, the La Tour Hospital has been the first private healthcare establishment in French-speaking Switzerland to adopt a "smarter medicine", a campaign which aims to promote rational and reasoned medical decisions, by eliminating certain unnecessary medical examinations and prescriptions, for a better quality of care delivered.
Seven common routine measures are currently evaluated. The aim is to avoid unnecessary prescription of three drugs: antibiotics, benzodiazepines for immobilization and proton pump inhibitors for stomach problems, and to study the relevance of certain radiological and biological examinations and blood transfusions and permanent catheters.
"It would be very short-sighted not to tackle quality improvement for the benefit of the patient. Our long-term goal is for patients to trust their hospital for the care they receive there, "concludes Rodolphe Eurin.
A major step towards a smarter and more sustainable medicine.
30 June